Skip to content

White Paper on OSSIOfiber Technology

← All Posts

Our proprietary material technology, OSSIOfiber® Intelligent Bone Regeneration Technology, has unique material composition and structural design that contribute to its strength and optimal bio-integration for orthopedic fixation. Scientific and clinical leaders at OSSIO discuss the science behind OSSIOfiber in this Technology Overview White Paper. 

Key Takeaways:

  • OSSIOfiber material composition creates the ideal bone fixation material that supports mechanical strength and balanced pH environment favorable for bone regeneration
  • The micro-architecture of thousands of continuous natural mineral fibers is engineered to create the optimal biomechanical properties in different mechanical axes for the clinical indications
  • As OSSIOfiber implants degrade, interconnected pores are formed allowing for fluid flow and regeneration of bone tissue in place of the implant
Screen Shot 2020-10-30 At 1.38.34 Pm

Through the material composition and internal architecture, OSSIOfiber is designed to provide both the mechanical strength required for insertion and secure fixation while having the ability to integrate into native bone without adverse inflammation. In doing so, OSSIOfiber Intelligent Bone Regeneration Technology creates a new category of fixation, called ‘Bio-Integratives’.

 

Learn more about material composition and structural design of OSSIOfiber Intelligent Bone Regeneration Technology.

 

Orahn Preiss-Bloom, Founder and Chief Innovation Officer

Orahn Preiss-Bloom, Founder and Chief Innovation Officer

Orahn is the Founder and Chief Innovation Officer at OSSIO. Previously, as founder and COO/CTO of LifeBond, Orahn developed two biosurgical product families to commercial stage and raised $60M, including from Johnson & Johnson Development Corporation. Prior, he was a biomechanics researcher at IDF Institute for Military Physiology and at Columbia University NY, Dept. of Orthopedic Surgery. Orahn has an M.Sc. in biomedical engineering from the Technion, Israel Institute of Technology.

Related Posts

All-Natural Modified Lapidus for Severe Hallux Valgus Correction 

Author: Garret Strand, DPM, Shasta Orthopaedics and Sports Medicine, CA. INTRODUCTION Hallux Abducto Valgus (HAV) (also referred to as Hallux Valgus (HV) or Bunion) is one of the most common deformities in the foot and ankle field. This pathological condition involves malpositioning of the first metatarsophalangeal (MTP) joint, caused by both a medial deviation ofContinue reading “All-Natural Modified Lapidus for Severe Hallux Valgus Correction “

Garret Strand, DPM, Shasta Orthopaedics and Sports Medicine, CA. September 5, 2024

Operative Fixation of a Transitional Ankle Fracture in a 14-year-Old Competitive Dancer, Using Bio-Integrative Implants

Author: Michael Morwood, MD, Atlantic Orthopaedics, Portsmouth, NH. INTRODUCTION The epiphyseal plate (known also as physis or growth plate) is a highly organized cartilage structure between the epiphyseal and metaphyseal bone at the distal ends of long bones. Fractures involving the epiphyseal plate are common musculoskeletal injuries occurring in children with open growth plates. PediatricContinue reading “Operative Fixation of a Transitional Ankle Fracture in a 14-year-Old Competitive Dancer, Using Bio-Integrative Implants”

Michael Morwood, MD, Atlantic Orthopaedics, Portsmouth, NH. June 20, 2024

All-Natural OSSIOfiber® Flatfoot Reconstruction

Author: Dallin Greene, DPM, Glendive Medical Center in Glendive, MT. Dr. Dallin Greene is a board-certified Foot and Ankle surgeon, treating all aspects of the foot and ankle with expertise in deformity correction. Dr. Greene graduated from Brigham Young University-Idaho in 2009 with a bachelor’s in biology. He then attended Midwestern University Arizona for aContinue reading “All-Natural OSSIOfiber® Flatfoot Reconstruction”

Dallin Greene April 2, 2024

Interested in OSSIOfiber®?

Complete the form and an OSSIOfiber® Advisor will get in touch.

Customer Service

For product inquiries or purchasing questions contact 833-781-7373 or email info@ossio.io

Address

Commercial Headquarters
OSSIO Inc
300 Tradecenter Drive, Suite 3690
Woburn, MA, 01801

Science & Manufacturing Center

OSSIO Ltd.
8 HaTochen Street
Cesarea, Israel 3079861

OSSIOfiber® has been used by 1500+ surgeons across the US

Footnotes

1. Data on file at OSSIO 2. Clinical study data on file at OSSIO 3. Kaiser, P.B., Watkins, I., Riedel, M. D., Cronin, P., Briceno, J., Kron, J. Y. (2019). Implant Removal Matrix for the Foot and Ankle Orthopaedic Surgeon. Foot & Ankle Specialist, 12(1), 79-97. https://doi.org/10.1177/1938640018791015 4. Pre-clinical animal studies (in-bone implantation of OSSIOfiber® and PLDLA control in rabbit femurs). Data on File at OSSIO. 5.Haddad, S. F., Helm, M. M., Meath, B., Adams, C., Packianathan, N., & Uhl, R. (2019). Exploring the Incidence, Implications, and Relevance of Metal Allergy to Orthopaedic Surgeons. Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 3(4), e023. https://doi.org/10.5435/JAAOSGlobal-D-19-00023